Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prasugrel vs Clopidogrel in Elective PCI for Complex Lesions
NCT04014803Phase 4Recruiting
- Sponsor
- Samsung Medical Center
- Start
- Jan 2020
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of prasugrel in coronary artery disease (CAD), sponsored by Samsung Medical Center. Started Jan 2020; status: recruiting.
02
Drugs
prasugrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT04014803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04014803.